BusinessRespireRx Pharmaceuticals Inc. Publishes Compelling Scientific Evidence Demonstrating the Neurobiological Safety of Ampakine CX717 and Justifying Continued Clinical DevelopmentBy Nasdaq OMXDec 18, 2017, 1:45 PM UTC